DK175575B1 - Benzodiazepinforbindelse og farmaceutisk præparat indeholdende en sådan forbindelse - Google Patents
Benzodiazepinforbindelse og farmaceutisk præparat indeholdende en sådan forbindelse Download PDFInfo
- Publication number
- DK175575B1 DK175575B1 DK198801395A DK139588A DK175575B1 DK 175575 B1 DK175575 B1 DK 175575B1 DK 198801395 A DK198801395 A DK 198801395A DK 139588 A DK139588 A DK 139588A DK 175575 B1 DK175575 B1 DK 175575B1
- Authority
- DK
- Denmark
- Prior art keywords
- cck
- gastrin
- compound
- formula
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/20—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/22—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/24—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2642087 | 1987-03-16 | ||
US07/026,420 US4820834A (en) | 1984-06-26 | 1987-03-16 | Benzodiazepine analogs |
Publications (3)
Publication Number | Publication Date |
---|---|
DK139588D0 DK139588D0 (da) | 1988-03-15 |
DK139588A DK139588A (da) | 1989-01-06 |
DK175575B1 true DK175575B1 (da) | 2004-12-13 |
Family
ID=21831732
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK198801395A DK175575B1 (da) | 1987-03-16 | 1988-03-15 | Benzodiazepinforbindelse og farmaceutisk præparat indeholdende en sådan forbindelse |
Country Status (18)
Country | Link |
---|---|
US (1) | US4820834A (de) |
EP (1) | EP0284256B1 (de) |
JP (1) | JP3039783B2 (de) |
KR (1) | KR960012197B1 (de) |
AT (1) | ATE106401T1 (de) |
AU (1) | AU1313388A (de) |
CA (1) | CA1332411C (de) |
CY (1) | CY1948A (de) |
DE (1) | DE3889756T2 (de) |
DK (1) | DK175575B1 (de) |
ES (1) | ES2052704T3 (de) |
HK (1) | HK157196A (de) |
IE (1) | IE64300B1 (de) |
IL (1) | IL85668A (de) |
MX (1) | MX9203479A (de) |
NZ (1) | NZ223772A (de) |
PT (1) | PT86980B (de) |
ZA (1) | ZA881866B (de) |
Families Citing this family (139)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01211939A (ja) * | 1988-02-18 | 1989-08-25 | Nec Kyushu Ltd | イオン注入装置 |
US5264433A (en) * | 1988-07-07 | 1993-11-23 | Fujisawa Pharmaceutical Co., Ltd. | Benzodiazepine derivatives |
US4970207A (en) * | 1988-07-07 | 1990-11-13 | Fujisawa Pharmaceutical Company, Ltd. | Benzodiazepine derivatives |
IL93401A (en) * | 1989-03-08 | 1994-08-26 | Kali Chemie Pharma Gmbh | H1 - Indole - 2 - Carboxylic acid 1, 7 - Consolidated N -) 1, 4 - Benzodiazepine - 3 - Il (amides, their preparation and drugs containing them |
ATE154135T1 (de) * | 1989-03-10 | 1997-06-15 | Hoffmann La Roche | Reagenzien zum nachweis von drogen |
EP0411668B2 (de) * | 1989-08-04 | 1998-11-11 | MERCK SHARP & DOHME LTD. | Zentrale Cholecystokinin-Antagonisten zur Behandlung von psychiatrischen Krankheiten |
FR2652352A1 (fr) * | 1989-09-28 | 1991-03-29 | Jouveinal Sa | Benzodiazepines, leur procede et intermediaires de preparation et leurs applications en therapeutique. |
US5175159A (en) * | 1989-10-05 | 1992-12-29 | Merck & Co., Inc. | 3-substituted-1,4-benzodiazepines as oxytocin antagonists |
CA2026856A1 (en) * | 1989-10-05 | 1991-04-06 | Mark G. Bock | 3-substituted-1,4-benzodiazepines useful as oxytocin |
US5324726A (en) * | 1989-12-18 | 1994-06-28 | Merck & Co., Inc. | Benzodiazepine analogs |
IE904560A1 (en) * | 1989-12-18 | 1991-06-19 | Merck & Co Inc | New benzodiazepine analogs |
US4994258A (en) * | 1990-03-05 | 1991-02-19 | Merck & Co., Inc. | Gamma emitting, CCK-A antagonists for pancreatic imaging |
GB9015879D0 (en) * | 1990-07-19 | 1990-09-05 | Fujisawa Pharmaceutical Co | Benzodiazepine derivatives |
US5206238A (en) * | 1990-11-13 | 1993-04-27 | Merck & Co., Inc. | Cholecystokinin antagonists |
US5136085A (en) * | 1990-11-28 | 1992-08-04 | Glaxo Inc. | Synthesis of 2-aminobenzophenones |
US5053543A (en) * | 1990-11-28 | 1991-10-01 | Glaxo Inc. | Synthesis of 2-aminobenzophenones |
CA2056809A1 (en) * | 1990-12-07 | 1992-06-08 | Mark G. Bock | Benzodiazepine analogs |
CA2099672A1 (en) * | 1990-12-25 | 1992-06-26 | Masato Satoh | Benzodiazepine derivatives |
IL101514A (en) * | 1991-04-10 | 1996-01-31 | Merck & Co Inc | History of benzodiazepines and anticoagulants containing cholecystokinin containing them |
US5220017A (en) * | 1991-04-10 | 1993-06-15 | Merck & Co., Inc. | Cholecystokinin antagonists |
US5220018A (en) * | 1991-04-10 | 1993-06-15 | Merck & Co., Inc. | Cholecystokinin antagonists |
US5218114A (en) * | 1991-04-10 | 1993-06-08 | Merck & Co., Inc. | Cholecystokinin antagonists |
US5218115A (en) * | 1991-04-10 | 1993-06-08 | Merck & Co., Inc. | Cholecystokinin antagonists |
US5340801A (en) * | 1991-05-08 | 1994-08-23 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Compounds having cholecystokinin and gastrin antagonistic properties |
US5185331A (en) * | 1991-05-14 | 1993-02-09 | Merck & Co., Inc. | Triazolobenzodiazepines |
US5206237A (en) * | 1991-05-14 | 1993-04-27 | Merck & Co., Inc. | Benzodiazepine analogs |
CA2068355A1 (en) * | 1991-05-14 | 1992-11-15 | Mark S. Chambers | Benzodiazephine derivatives, compositions containing them and their use in therapy |
US5210082A (en) * | 1991-05-16 | 1993-05-11 | Merck & Co., Inc. | 2-benzazepines with 5- and 6-membered heterocyclic rings to treat pain and anxiety disorders |
US5189050A (en) * | 1991-06-03 | 1993-02-23 | Merck & Co., Inc. | Fermentation analogs of virginiamycin m1 to treat panic and anxiety disorder |
CA2071181A1 (en) * | 1991-06-14 | 1992-12-15 | Roger M. Freidinger | Benzodiazepine analogs |
US5177071A (en) * | 1991-06-17 | 1993-01-05 | Merck & Co., Inc. | 1,4-benzodiazepines with 6-membered heterocyclic rings to treat panic and anxiety disorder |
US5939412A (en) * | 1992-06-26 | 1999-08-17 | Smithkline Beecham Corporation | Bicyclic fibrinogen antagonists |
WO1993000095A2 (en) * | 1991-06-28 | 1993-01-07 | Smithkline Beecham Corporation | Bicyclic fibrinogen antagonists |
GB9116113D0 (en) * | 1991-07-25 | 1991-09-11 | Merck Sharp & Dohme | Therapeutic agents |
US5153191A (en) * | 1991-08-20 | 1992-10-06 | Warner-Lambert Company | Cholecystokinin antagonists useful for treating depression |
US5217957A (en) * | 1991-08-20 | 1993-06-08 | Warner-Lambert Company | Cholecystokinin antagonists useful for treating depression |
WO1993007129A1 (en) * | 1991-10-11 | 1993-04-15 | Yoshitomi Pharmaceutical Industries, Ltd. | Remedy for osteoporosis and diazepine compound |
US5428031A (en) * | 1991-12-03 | 1995-06-27 | Merck & Co., Inc. | Methods of treating cardiac arrhythmia |
EP0549039B1 (de) * | 1991-12-20 | 1995-08-09 | MERCK SHARP & DOHME LTD. | 3-Phenylureido-1,4-Benzodiazepinone und ihre Verwendung als Cholecystokinin- oder Gastrinantagonisten |
JPH07507993A (ja) * | 1991-12-20 | 1995-09-07 | メルク シヤープ エンド ドーム リミテツド | 医薬活性を有する中枢神経系コレシストキニンアンタゴニスト |
GB9203790D0 (en) * | 1992-02-21 | 1992-04-08 | Merck Sharp & Dohme | Therapeutic agents |
IL104853A (en) * | 1992-02-27 | 1997-11-20 | Yamanouchi Pharma Co Ltd | Benzodiazepine derivatives, their preparation and pharmaceutical compositions containing them |
GB2264492B (en) * | 1992-02-27 | 1996-09-25 | Yamanouchi Pharma Co Ltd | Benzodiazepine derivatives |
GB9209518D0 (en) * | 1992-05-01 | 1992-06-17 | Merck Sharp & Dohme | Therapeutic agents |
GB2266528A (en) * | 1992-05-01 | 1993-11-03 | Merck Sharp & Dohme | Benzodiazepine derivatives |
US5360802A (en) * | 1992-05-11 | 1994-11-01 | Merck Sharpe & Dohme Ltd. | Benzodiazepine derivatives, compositions containing them and their use in therapy |
US5378838A (en) * | 1993-01-13 | 1995-01-03 | Merck & Co., Inc. | Benzodiazepine cholecystokinin antagonists |
JP3419539B2 (ja) * | 1993-02-17 | 2003-06-23 | 中外製薬株式会社 | インドリン−2−オン誘導体 |
EP0763537A3 (de) | 1993-05-14 | 1997-10-22 | Genentech Inc | Nichtpeptide Farnesyltransferas Inhibitoren |
GB2282595A (en) * | 1993-08-25 | 1995-04-12 | Yamanouchi Pharma Co Ltd | Benzodiazepine derivatives |
GB2282594A (en) * | 1993-08-25 | 1995-04-12 | Yamanouchi Pharma Co Ltd | Benzodiazepine derivatives |
AU678503B2 (en) * | 1993-09-24 | 1997-05-29 | Takeda Chemical Industries Ltd. | Condensed heterocyclic compounds and their use as squalene synthetase inhibitors |
JPH09505597A (ja) * | 1993-11-22 | 1997-06-03 | メルク エンド カンパニー インコーポレーテッド | 3−アシルアミノベンゾアゼピン類 |
US5428157A (en) * | 1993-11-22 | 1995-06-27 | Merck & Co., Inc. | 3-acylaminobenzodiazepines |
US5438055A (en) * | 1993-11-22 | 1995-08-01 | Merck & Co., Inc. | Antiarrhythmic benzodiazepines |
US5426185A (en) * | 1993-11-22 | 1995-06-20 | Merck & Co., Inc. | Antiarrhythmic benzodiazepines |
MA23420A1 (fr) * | 1994-01-07 | 1995-10-01 | Smithkline Beecham Corp | Antagonistes bicycliques de fibrinogene. |
US5580979A (en) * | 1994-03-15 | 1996-12-03 | Trustees Of Tufts University | Phosphotyrosine peptidomimetics for inhibiting SH2 domain interactions |
US5739129A (en) * | 1994-04-14 | 1998-04-14 | Glaxo Wellcome Inc. | CCK or gastrin modulating 5-heterocyclic-1, 5 benzodiazepines |
US5795887A (en) * | 1994-04-15 | 1998-08-18 | Glaxo Wellcome Inc. | Method of inducing cholecystokinin agonist activity using 1,4- Benzodiazepine compounds |
PE27497A1 (es) * | 1994-04-15 | 1997-08-07 | Glaxo Inc | Derivados de 1,5 benzodiazepina |
US6458784B1 (en) | 1994-06-29 | 2002-10-01 | Smithkline Beecham Corporation | Vitronectin receptor antagonists |
JPH10504545A (ja) * | 1994-07-29 | 1998-05-06 | 藤沢薬品工業株式会社 | ベンゾジアゼピン誘導体 |
EP0776203A4 (de) * | 1994-08-18 | 1997-12-29 | Merck & Co Inc | N-2,3-dihydro-1-(2-propyl)-2-oxo-5-phenyl-1h-1,4-benzodiazepine |
EP0776208B1 (de) * | 1994-08-18 | 1999-11-10 | Merck & Co. Inc. | 2,3-dihydro-1-(2,2,2-trifluorethyl)-2-oxo-5-phenyl-1h-1,4-benzodiazepine |
US5556969A (en) * | 1994-12-07 | 1996-09-17 | Merck Sharp & Dohme Ltd. | Benzodiazepine derivatives |
WO1996017833A1 (en) * | 1994-12-09 | 1996-06-13 | Smithkline Beecham Corporation | Bicyclic fibrinogen antagonists |
US5726171A (en) * | 1995-06-07 | 1998-03-10 | Merck & Co Inc | N-(1-alkyl-5-phenyl-2,3,4,5-tetrahydro-1H-benzo B! 1,4!diazepin-3yl)-acetamides |
US5691331A (en) * | 1995-06-07 | 1997-11-25 | Merck & Co., Inc. | N-(2,4-Dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3yl) -3- amides |
US5631251A (en) * | 1995-06-07 | 1997-05-20 | Merck & Co., Inc. | 5-cyclopropyl-1,4 benzodiazepine-2-ones |
US5700797A (en) * | 1995-06-07 | 1997-12-23 | Merck & Co, Inc. | N-(2,4-dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3-yl)-3-amides |
DE69626981T2 (de) * | 1995-06-07 | 2003-12-18 | Merck & Co Inc | N-(2-oxo-2,3,4,5-tetrahydro-1h-1,5-benzodiazepin-3-yl)-3-amide |
US5977101A (en) * | 1995-06-29 | 1999-11-02 | Smithkline Beecham Corporation | Benzimidazoles/Imidazoles Linked to a Fibrinogen Receptor Antagonist Template Having Vitronectin Receptor Antagonist Activity |
JP2000510155A (ja) * | 1996-06-28 | 2000-08-08 | メルク エンド カンパニー インコーポレーテッド | 医薬製剤 |
US5776930A (en) * | 1996-06-28 | 1998-07-07 | Merck & Company, Inc. | Pharmaceutical preparation |
TW414795B (en) * | 1996-07-01 | 2000-12-11 | Yamanouchi Pharma Co Ltd | A thiophene derivative and the pharmaceutical composition |
US5929071A (en) * | 1996-07-02 | 1999-07-27 | Merck & Co., Inc. | Method for the treatment of preterm labor |
AUPO284396A0 (en) * | 1996-10-08 | 1996-10-31 | Fujisawa Pharmaceutical Co., Ltd. | Benzodiazepine derivatives |
US5939414A (en) * | 1996-10-31 | 1999-08-17 | Merck & Co., Inc. | Benzodiazepine hydrazide derivatives as inhibitors of HIV integrase |
CA2269135A1 (en) * | 1996-10-31 | 1998-05-07 | Merck & Co., Inc. | Benzodiazepine hydrazide derivatives as inhibitors of hiv integrase |
US6683075B1 (en) | 1996-12-23 | 2004-01-27 | Athena Neurosciences, Inc. | Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use |
US6635632B1 (en) | 1996-12-23 | 2003-10-21 | Athena Neurosciences, Inc. | Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
DE19742508A1 (de) | 1997-09-26 | 1999-04-01 | Hoechst Marion Roussel De Gmbh | Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen |
JP3613005B2 (ja) | 1998-05-15 | 2005-01-26 | オムロン株式会社 | 圧力センサ及びドア開閉監視システム |
US6528505B1 (en) | 1998-06-22 | 2003-03-04 | Elan Pharmaceuticals, Inc. | Cyclic amino acid compounds pharmaceutical compositions comprising same and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
US6552013B1 (en) | 1998-06-22 | 2003-04-22 | Elan Pharmaceuticals, Inc. | Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
US6958330B1 (en) | 1998-06-22 | 2005-10-25 | Elan Pharmaceuticals, Inc. | Polycyclic α-amino-ε-caprolactams and related compounds |
US6774125B2 (en) | 1998-06-22 | 2004-08-10 | Elan Pharmaceuticals, Inc. | Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
US6569851B1 (en) | 1998-06-22 | 2003-05-27 | Elan Pharmaceutials, Inc. | Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
US6509331B1 (en) | 1998-06-22 | 2003-01-21 | Elan Pharmaceuticals, Inc. | Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
FR2782997A1 (fr) * | 1998-09-08 | 2000-03-10 | Hoechst Marion Roussel Inc | Nouveaux derives de la benzodiazepinone, procede de preparation et intermediaires de ce procede, application a titre de medicaments et compositions pharmaceutiques les renfermant |
IL146222A0 (en) | 1999-04-30 | 2002-07-25 | Univ Michigan | Therapeutic applications of pro-apoptotic benzodiazepines |
US20060025388A1 (en) * | 1999-04-30 | 2006-02-02 | Glick Gary D | Compositions and methods relating to novel compounds and targets thereof |
US20050113460A1 (en) * | 1999-04-30 | 2005-05-26 | The Regents Of The University Of Michigan | Compositions and methods relating to novel compounds and targets thereof |
US7144880B2 (en) * | 1999-04-30 | 2006-12-05 | Regents Of The University Of Michigan | Compositions relating to novel compounds and targets thereof |
US6150357A (en) * | 1999-05-10 | 2000-11-21 | Merck & Co., Inc. | Potassium channel agonists |
US7160880B1 (en) | 1999-05-14 | 2007-01-09 | Cenes Limited | Short-acting benzodiazepines |
JP2003506440A (ja) * | 1999-08-05 | 2003-02-18 | プレサイエント ニューロファーマ インコーポレイテッド | 中枢神経系に関連する疾患の処置のための1,4−ジアゼピン誘導体 |
AU776283B2 (en) | 1999-12-02 | 2004-09-02 | Zeria Pharmaceutical Co., Ltd. | Calcium salts of 1,5-benzodiazepine derivatives, process for producing the salts and drugs containing the same |
SE0104250D0 (sv) * | 2001-12-14 | 2001-12-14 | Astrazeneca Ab | Heterocyclic compounds |
BR0314595A (pt) | 2002-09-20 | 2005-08-09 | Arrow Therapeutics Ltd | Uso de um derivado de benzodiazepina ou um sal farmaceuticamente aceitável deste, inalador ou nebulisador, produto, usos de um produto e de um composto ou sal farmaceuticamente aceitável deste, derivado de benzodiazepina, composto, e, composição farmacêutica |
JP2004346059A (ja) * | 2003-01-28 | 2004-12-09 | Takeda Chem Ind Ltd | 受容体作動薬 |
EP1591120A4 (de) * | 2003-01-28 | 2009-06-10 | Takeda Chemical Industries Ltd | Rezeptor-agonisten |
GB0406279D0 (en) * | 2004-03-19 | 2004-04-21 | Arrow Therapeutics Ltd | Therapeutic compounds |
US20050272723A1 (en) * | 2004-04-27 | 2005-12-08 | The Regents Of The University Of Michigan | Methods and compositions for treating diseases and conditions associated with mitochondrial function |
US20060052369A1 (en) * | 2004-09-07 | 2006-03-09 | The Regents Of The University Of Michigan | Compositions and methods relating to novel compounds and targets thereof |
AU2006203946B2 (en) | 2005-01-03 | 2009-07-23 | The Regents Of The University Of Michigan | Compositions and methods relating to novel compounds and targets thereof |
WO2007053193A2 (en) * | 2005-06-01 | 2007-05-10 | The Regents Of The University Of Michigan | Unsolvated benzodiazepine compositions and methods |
US8053413B2 (en) * | 2005-06-06 | 2011-11-08 | The Board Of Trustees Of The University Of Illinois | Methods for treating sleep disorders by cholecystokinin (CCK) receptor B antagonists |
MX2008003369A (es) * | 2005-09-19 | 2008-03-27 | Arrow Therapeutics Ltd | Derivados de benzodiazepina para tratar infeccion de hepatitis c. |
WO2007053725A2 (en) | 2005-11-01 | 2007-05-10 | The Regents Of The University Of Michigan | Novel 1,4-benzodiazepine-2,5-diones with therapeutic properties |
US7759338B2 (en) * | 2006-04-27 | 2010-07-20 | The Regents Of The University Of Michigan | Soluble 1,4 benzodiazepine compounds and stable salts thereof |
CA2659549C (en) * | 2006-06-09 | 2013-07-30 | The Regents Of The University Of Michigan | Compositions and methods relating to novel compounds and targets thereof |
KR20090045233A (ko) | 2006-07-10 | 2009-05-07 | 파이온 유케이 리미티드 | 속효형 벤조디아제핀 염 및 이의 중합체 형태 |
BRPI0808653A2 (pt) * | 2007-03-09 | 2014-08-19 | Univ Michigan | Composições e métodos referindo-se a novos compostos e alvos dos mesmos. |
KR20100017766A (ko) * | 2007-05-10 | 2010-02-16 | 에이엠알 테크놀로지, 인크. | 아릴- 및 헤테로아릴-치환된 테트라히드로벤조-1,4-디아제핀 및 노르에피네프린, 도파민 및 세로토닌의 재흡수를 차단하기 위한 이의 용도 |
US8324258B2 (en) | 2007-09-14 | 2012-12-04 | The Regents Of The University Of Michigan | F1F0-ATPase inhibitors and related methods |
RU2010122902A (ru) | 2007-11-06 | 2011-12-20 | Дзе Риджентс оф дзе Юниверсити оф Мичиган (US) | Бензодиапениноновые соединения, применимые в лечении кожных состояний |
EP2352724B1 (de) | 2008-09-11 | 2015-04-22 | The Regents of the University of Michigan | Arylguanidine-f1f0-aptase inhibitoren und deren therapeutischen verwendung |
WO2010121164A2 (en) | 2009-04-17 | 2010-10-21 | The Regents Of The University Of Michigan | 1,4-benzodiazepinone compounds and their use in treating cancer |
EP2470020A4 (de) | 2009-09-18 | 2013-03-13 | Univ Michigan | Benzodiazepinonverbindungen und behandlungsverfahren damit |
CA2915237C (en) | 2009-11-17 | 2017-10-10 | The Regents Of The University Of Michigan | 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties |
ES2703752T3 (es) | 2009-11-17 | 2019-03-12 | Univ Michigan Regents | 1,4-Benzodiazepina-2,5-dionas y compuestos relacionados que presentan propiedades terapéuticas |
EP2450039A1 (de) | 2010-11-08 | 2012-05-09 | PAION UK Ltd. | Dosierschema zur Sedierung mit CNS 7056 (Remimazolam) |
WO2012075456A1 (en) | 2010-12-02 | 2012-06-07 | Constellation Pharmaceuticals | Bromodomain inhibitors and uses thereof |
AR084070A1 (es) | 2010-12-02 | 2013-04-17 | Constellation Pharmaceuticals Inc | Inhibidores del bromodominio y usos de los mismos |
EP2705039B1 (de) | 2011-05-04 | 2017-07-26 | Constellation Pharmaceuticals, Inc. | Bromodomainhemmer und ihre verwendung |
EP2721031B1 (de) | 2011-06-17 | 2016-01-20 | Constellation Pharmaceuticals, Inc. | Bromodomainhemmer und ihre verwendungen |
WO2013184878A1 (en) | 2012-06-06 | 2013-12-12 | Constellation Pharmaceuticals, Inc. | Benzo [b] isoxazoloazepine bromodomain inhibitors and uses thereof |
TWI602820B (zh) | 2012-06-06 | 2017-10-21 | 星宿藥物公司 | 溴域抑制劑及其用途 |
AR094963A1 (es) | 2013-03-04 | 2015-09-09 | Ono Pharmaceutical Co | Reacción de oxidación excelente en el índice de conversión |
US9969747B2 (en) | 2014-06-20 | 2018-05-15 | Constellation Pharmaceuticals, Inc. | Crystalline forms of 2-((4S)-6-(4-chlorophenyl)-1-methyl-4H-benzo[C]isoxazolo[4,5-e]azepin-4-yl)acetamide |
GB201414116D0 (en) * | 2014-08-08 | 2014-09-24 | Trio Medicines Ltd | Benzodiazepine derivatives |
GB201513979D0 (en) | 2015-08-07 | 2015-09-23 | Trio Medicines Ltd | Synthesis of benzodiazepine derivatives |
US11547706B2 (en) | 2016-06-08 | 2023-01-10 | President And Fellows Of Harvard College | Methods and compositions for reducing tactile dysfunction and anxiety associated with autism spectrum disorder, Rett syndrome, and Fragile X syndrome |
GB201613942D0 (en) | 2016-08-15 | 2016-09-28 | Univ Of Durham The | An antimicrobial compound |
AU2019279858A1 (en) | 2018-05-29 | 2020-11-26 | President And Fellows Of Harvard College | Compositions and methods for reducing tactile dysfunction, anxiety, and social impairment |
WO2020198275A1 (en) * | 2019-03-25 | 2020-10-01 | President And Fellows Of Harvard College | Compositions and methods for reducing tactile dysfunction, anxiety, and social impairment |
CA3220039A1 (en) | 2021-06-14 | 2022-12-22 | Jr. David St. Jean | Urea derivatives which can be used to treat cancer |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3198789A (en) * | 1965-08-03 | Certain j-amino-s-phenyl-l,j-dihydro-zh- l,x-benzxraazepin-z-qnx c compounds | ||
CH408045A (de) * | 1959-12-10 | 1966-02-28 | Hoffmann La Roche | Verfahren zur Herstellung von Benzophenonderivaten |
US3402171A (en) * | 1960-12-02 | 1968-09-17 | Hoffmann La Roche | Process for preparing 5-aryl-3h-1, 4-benzodiazepin-2(1h)-ones |
US3336295A (en) * | 1960-12-02 | 1967-08-15 | Hoffmann La Roche | Hydroxy or alkoxy substituted 5-phenyl-3h-1, 4-benzodiazepin-2(1h)-ones |
US3297755A (en) * | 1960-12-02 | 1967-01-10 | Hoffmann La Roche | 2-chloro-5-trifluoromethylbenzo-phenone compounds |
GB1034872A (en) * | 1962-04-16 | 1966-07-06 | American Home Prod | Benzodiazepine derivatives |
BE656606A (de) * | 1963-12-03 | |||
GB1056289A (en) * | 1964-01-14 | 1967-01-25 | Delmar Chem | 2-phthalimido acetamido benzophenones and their preparation |
GB1039947A (en) * | 1964-04-06 | 1966-08-24 | Engelhard Ind Inc | Improvements in or relating to gold plating |
US3418315A (en) * | 1966-02-14 | 1968-12-24 | American Home Prod | Preparation of 7-chloro-1,3-dihydro-3-diethylamino - 3 - methyl - 5 - phenyl - 2h - 1,4-benzodiazepin-2-one |
GB1173320A (en) * | 1966-12-13 | 1969-12-10 | Delmar Chem | Derivatives of Benzodiazepinones |
US3558603A (en) * | 1967-12-01 | 1971-01-26 | Sumitomo Chemical Co | Process for producing benzodiazepine derivatives |
US3899527A (en) * | 1969-02-26 | 1975-08-12 | American Home Prod | Intermediates for the preparation of 1,3-dihydro-2H-1,4-benzodiazepin-2-ones |
US3778433A (en) * | 1969-04-18 | 1973-12-11 | Sumitomo Chemical Co | Process for producing benzodiazepine derivatives |
DE1923821A1 (de) * | 1969-05-09 | 1970-11-19 | Wuelfing J A Fa | 1,2,4,5-Tetrahydro-[3H]-benzo-1,4-diazepin-2,5-dion-Derivate,Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von Arzneipraeparaten |
US3867529A (en) * | 1970-08-24 | 1975-02-18 | Giorgio Ferrari | Tranquilizing and anti-anxiety pharmaceutical compositions |
US4045569A (en) * | 1971-03-17 | 1977-08-30 | Franjo Kajfez | Optically active 1,4-benzodiazepines and process for use as a tranquilizer |
US4065451A (en) * | 1971-03-30 | 1977-12-27 | American Home Products | 1,3-Dihydro-3-hydroxy-5-phenyl-2H-1,4-benzodiazepin-2-one, substituted diamino acetate esters and their acid salts |
US3801568A (en) * | 1972-02-07 | 1974-04-02 | American Home Prod | Optically active 1,3-dihydro-3-substituted 5-phenyl-2h-1,4-benzodiazepin-2-ones and process for their separation |
CH581606A5 (en) * | 1972-08-02 | 1976-11-15 | Crc Ricerca Chim | 2-(Alpha-ammonio-acylamino) benzophenones - precursors for benzodiazepinone hypnotics and tranquillisers |
JPS49102688A (de) * | 1973-02-14 | 1974-09-27 | ||
DE2311714A1 (de) * | 1973-03-09 | 1974-09-19 | Thomae Gmbh Dr K | Neue 1,4-benzodiazepine |
CH573928A5 (de) * | 1973-07-30 | 1976-03-31 | Crc Ricerca Chim | |
US4530790A (en) * | 1982-12-27 | 1985-07-23 | Merck & Co., Inc. | Cholecystokinin antagonists |
US4755508A (en) * | 1984-06-26 | 1988-07-05 | Merck & Co., Inc. | Benzodiazepine analogs and use as antogonists of gastrin and cholecystokinin |
EP0167920A3 (de) * | 1984-06-26 | 1986-11-05 | Merck & Co. Inc. | Benzodiazepin-Derivate und diese enthaltende Arzneimittel |
CA1332410C (en) * | 1984-06-26 | 1994-10-11 | Roger M. Freidinger | Benzodiazepine analogs |
-
1987
- 1987-03-16 US US07/026,420 patent/US4820834A/en not_active Expired - Lifetime
-
1988
- 1988-03-07 NZ NZ223772A patent/NZ223772A/xx unknown
- 1988-03-08 IL IL8566888A patent/IL85668A/en not_active IP Right Cessation
- 1988-03-11 CY CY194888A patent/CY1948A/xx unknown
- 1988-03-11 AT AT88302141T patent/ATE106401T1/de not_active IP Right Cessation
- 1988-03-11 ES ES88302141T patent/ES2052704T3/es not_active Expired - Lifetime
- 1988-03-11 EP EP88302141A patent/EP0284256B1/de not_active Expired - Lifetime
- 1988-03-11 DE DE3889756T patent/DE3889756T2/de not_active Expired - Fee Related
- 1988-03-15 KR KR1019880002698A patent/KR960012197B1/ko not_active IP Right Cessation
- 1988-03-15 AU AU13133/88A patent/AU1313388A/en not_active Abandoned
- 1988-03-15 DK DK198801395A patent/DK175575B1/da not_active IP Right Cessation
- 1988-03-15 PT PT86980A patent/PT86980B/pt not_active IP Right Cessation
- 1988-03-15 IE IE75588A patent/IE64300B1/en not_active IP Right Cessation
- 1988-03-15 CA CA000561493A patent/CA1332411C/en not_active Expired - Fee Related
- 1988-03-16 JP JP63060643A patent/JP3039783B2/ja not_active Expired - Fee Related
- 1988-03-16 ZA ZA881866A patent/ZA881866B/xx unknown
-
1992
- 1992-06-26 MX MX9203479A patent/MX9203479A/es unknown
-
1996
- 1996-08-15 HK HK157196A patent/HK157196A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
IE880755L (en) | 1988-09-16 |
EP0284256A1 (de) | 1988-09-28 |
IL85668A (en) | 1995-03-30 |
NZ223772A (en) | 1991-09-25 |
PT86980A (pt) | 1988-04-01 |
EP0284256B1 (de) | 1994-06-01 |
JPS63238069A (ja) | 1988-10-04 |
ES2052704T3 (es) | 1994-07-16 |
ATE106401T1 (de) | 1994-06-15 |
KR880011126A (ko) | 1988-10-26 |
DK139588D0 (da) | 1988-03-15 |
HK157196A (en) | 1996-08-23 |
DK139588A (da) | 1989-01-06 |
MX9203479A (es) | 1992-08-01 |
US4820834A (en) | 1989-04-11 |
PT86980B (pt) | 1992-06-30 |
JP3039783B2 (ja) | 2000-05-08 |
CA1332411C (en) | 1994-10-11 |
IL85668A0 (en) | 1988-08-31 |
DE3889756T2 (de) | 1994-12-08 |
CY1948A (en) | 1988-03-11 |
AU1313388A (en) | 1988-09-15 |
DE3889756D1 (de) | 1994-07-07 |
KR960012197B1 (ko) | 1996-09-16 |
IE64300B1 (en) | 1995-07-26 |
ZA881866B (en) | 1988-09-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK175575B1 (da) | Benzodiazepinforbindelse og farmaceutisk præparat indeholdende en sådan forbindelse | |
US5324726A (en) | Benzodiazepine analogs | |
EP0434364A2 (de) | Benzodiazepinanaloge zur Behandlung von Angstzuständen und zur direkten Analgesie | |
AU679085B2 (en) | Benzodiazepine analogs | |
IE904560A1 (en) | New benzodiazepine analogs | |
IE904556A1 (en) | New benzodiazepine analogs | |
CA2056809A1 (en) | Benzodiazepine analogs | |
NO173651B (no) | Analogifremgnagsmaate ved fremstilling av terapeutisk aktive benzodiazepinanaloger | |
US5162336A (en) | Tetrahydro-pyrido-indoles as cholecystokinin and gastrin antagonists | |
US5177071A (en) | 1,4-benzodiazepines with 6-membered heterocyclic rings to treat panic and anxiety disorder | |
JPH05255279A (ja) | コレシストキニン拮抗薬 | |
EP0523845A2 (de) | Neue Benzodiazepin Analoge | |
US4847248A (en) | 1,4-Benzodiazepines with 5- and 6-membered heterocyclic rings and their use as cholecystokinins and gastrin antagonists | |
EP0304223A2 (de) | Beta-Carboline als Cholecystokinin und Gastrin-Antagonist | |
JPS63227574A (ja) | ベンゾジアゼピン類似体 | |
EP0272866A1 (de) | 1,4-Benzodiazepine mit 5-gliedrigen heterocyclischen Ringen | |
JPH0680649A (ja) | コレシストキニン拮抗剤 | |
US4735941A (en) | 1,4-benzodiazepines with 5- and 6-membered heterocyclic rings, useful as gastrointestinal and CNS agents | |
EP0523846A2 (de) | 1,4-Benzodiazepine mit 5-gliedrigen heterozyklischen Ringen | |
EP0273697A2 (de) | 2-Benzazepine mit 5- und 6-gliedrigen heterozyklischen Ringen | |
EP0272868A1 (de) | 1,4-Benzodiazepine mit 6-gliedrigen heterozyklischen Ringen | |
EP0518484A2 (de) | Mit fünf- oder sechsgliedrigen heterozyklischen Ringverbindungen kondensierte 1,4-Benzodiazepine zur Behandlung von Angstzuständen, Schmerz, Pupillenkontraktion, Entzugserscheinungen oder onkologischen Erkrankungen | |
US5206238A (en) | Cholecystokinin antagonists | |
JPS6115835A (ja) | コレシストキニン拮抗薬 | |
EP0486271A2 (de) | Cholecystokinin-Antagonisten zur Behandlung von neurologischen Erkrankungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PBP | Patent lapsed |
Country of ref document: DK |